PECAM1 and acute myeloid leukemia: PECAM-1 is also expressed on various types of leukemias, including acute myeloid leukemia (AML) (8), acute lymphoblastic leukemia (ALL) (9), and chronic lymphocytic leukemia (CLL) (10,11), and has been implicated in prognosis of CLL, although it remains controversial.